119
Milestone Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
71.8
FY23:
73.0
FY24:
73.9
FY25:
112
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.93
FY22:
2.68
FY23:
2.19
FY24:
1.57
FY25:
1.64
Total assets
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
74.5
FY23:
75.2
FY24:
75.5
FY25:
114
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.78
FY22:
6.14
FY23:
7.23
FY24:
8.13
FY25:
14.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.47
FY22:
2.00
FY23:
51.2
FY24:
54.2
FY25:
57.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
113
FY22:
66.3
FY23:
16.8
FY24:
13.1
FY25:
41.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
74.5
FY23:
75.2
FY24:
75.5
FY25:
114
All amounts in millions USD